The release of the fourth quarter and full-year 2025 results will serve as a comprehensive health check, moving beyond quarterly performance to evaluate the company's broader strategic pivot. The core ...

In a sudden reversal, the U.S. Food and Drug Administration (FDA) has agreed to review Moderna’s experimental mRNA influenza vaccine.

The CDC revised the guidance for immunizations, which one attorney general described as "scientifically unsound" and ...

Researchers summarize key insights from the world’s first comprehensive investigation into how a pandemic started.

In a sudden reversal, the US Food and Drug Administration has agreed to review Moderna’s experimental mRNA influenza vaccine.

The move might at first sound like little more than a reduced hassle—and maybe reckless, since there was good evidence in ...

Foreign substances such as mold, hair, and silicon dioxide (silica) were found in COVID-19 vaccines, potentially introduced ...

A 2023 law championed by Republicans requires the CDC have a director confirmed by the Senate. For months, though, it’s had ...

Researchers suggest a vaccine could replace multiple jabs every year for seasonal respiratory infections and be on hand in the event of a new pandemic.

Just last week, the agency rejected Moderna’s initial application, citing flaws in the company’s research design.

Moderna held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.